Vir Biotechnology, Inc. VIR Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s common stock, shares issued (in shares)?
- Vir Biotechnology, Inc. (VIR) reported common stock, shares issued (in shares) of $161.23M in Q1 2026.
- How has Vir Biotechnology, Inc.'s common stock, shares issued (in shares) changed year-over-year?
- Vir Biotechnology, Inc.'s common stock, shares issued (in shares) increased by 16.8% year-over-year, from $138.06M to $161.23M.
- What is the long-term trend for Vir Biotechnology, Inc.'s common stock, shares issued (in shares)?
- Over 3 years (2022 to 2025), Vir Biotechnology, Inc.'s common stock, shares issued (in shares) has grown at a 1.5% compound annual growth rate (CAGR), from $133.24M to $139.47M.